ArticleDrug design, development and therapy2026
Gradient Boosting Machine-Based Prognostic Model with SurvSHAP Analysis for Predicting Secondary Loss of Response to Infliximab Therapy in Crohn's Disease.
Yu-Qing Guo et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.